Safe Practices Recommendations for Healthcare
Professionals:
• At patient admission/presentation and
periodically throughout the patient’s stay at the
facility, assess the presence and use of therapies
containing interfering drugs (see previous page).
• Use only laboratory methods for monitoring
blood glucose levels in patients receiving
interfering drugs.
• If there are pre-print order sets for patients
receiving interfering drugs, include a
prescription to test blood glucose using only
laboratory methods.
• Establish facility protocols to verify point-of-
care (bedside) blood glucose results with
laboratory results for patients who are
unresponsive or unable to communicate.
4
T2go_OB_GutsENG_F4HDI04.qxd:TT_OB_GutsENG.qxd 1/29/10 10:38 AM Page 4
